The global hemophilia market, encompassing Hemophilia A, B, and related therapies, is projected to reach around USD 21.07 billion by 2030, expanding at ~6.6–6.9% CAGR from 2023 to 2030 Alternative analyses forecast accelerated growth of 12%+ CAGR, reaching USD 57.7 billion by 2034, driven by innovative therapies .
Sample report :...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek